Literature DB >> 24115813

Alteration in gene expression profile and oncogenicity of esophageal squamous cell carcinoma by RIZ1 upregulation.

Shang-Wen Dong1, Dong Li, Cong Xu, Pei Sun, Yuan-Guo Wang, Peng Zhang.   

Abstract

AIM: To investigate the effect of retinoblastoma protein-interacting zinc finger gene 1 (RIZ1) upregulation in gene expression profile and oncogenicity of human esophageal squamous cell carcinoma (ESCC) cell line TE13.
METHODS: TE13 cells were transfected with pcDNA3.1(+)/RIZ1 and pcDNA3.1(+). Changes in gene expression profile were screened and the microarray results were confirmed by reverse transcription-polymerase chain reaction (RT-PCR). Nude mice were inoculated with TE13 cells to establish ESCC xenografts. After two weeks, the inoculated mice were randomly divided into three groups. Tumors were injected with normal saline, transfection reagent pcDNA3.1(+) and transfection reagent pcDNA3.1(+)/RIZ1, respectively. Tumor development was quantified, and changes in gene expression of RIZ1 transfected tumors were detected by RT-PCR and Western blotting.
RESULTS: DNA microarray data showed that RIZ1 transfection induced widespread changes in gene expression profile of cell line TE13, with 960 genes upregulated and 1163 downregulated. Treatment of tumor xenografts with RIZ1 recombinant plasmid significantly inhibited tumor growth, decreased tumor size, and increased expression of RIZ1 mRNA compared to control groups. The changes in gene expression profile were also observed in vivo after RIZ1 transfection. Most of the differentially expressed genes were associated with cell development, supervision of viral replication, lymphocyte costimulatory and immune system development in esophageal cells. RIZ1 gene may be involved in multiple cancer pathways, such as cytokine receptor interaction and transforming growth factor beta signaling.
CONCLUSION: The development and progression of esophageal cancer are related to the inactivation of RIZ1. Virus infection may also be an important factor.

Entities:  

Keywords:  Esophageal squamous cell carcinoma cells; Microarray; Nude mice; Retinoblastoma protein-interacting zinc finger gene 1

Mesh:

Substances:

Year:  2013        PMID: 24115813      PMCID: PMC3787346          DOI: 10.3748/wjg.v19.i37.6170

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

1.  Transglutaminase-3, an esophageal cancer-related gene.

Authors:  B S Chen; M R Wang; X Xu; Y Cai; Z X Xu; Y L Han; M Wu
Journal:  Int J Cancer       Date:  2000-12-15       Impact factor: 7.396

Review 2.  Esophageal cancer.

Authors:  Peter C Enzinger; Robert J Mayer
Journal:  N Engl J Med       Date:  2003-12-04       Impact factor: 91.245

3.  The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein.

Authors:  I M Buyse; G Shao; S Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

4.  Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis.

Authors:  R B Chadwick; G L Jiang; G A Bennington; B Yuan; C K Johnson; M W Stevens; T H Niemann; P Peltomaki; S Huang; A de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

5.  Altered expression of retinoblastoma protein-interacting zinc finger gene, RIZ, in human leukaemia.

Authors:  Osamu Sasaki; Kuniaki Meguro; Yasuo Tohmiya; Tadao Funato; Shigeki Shibahara; Takeshi Sasaki
Journal:  Br J Haematol       Date:  2002-12       Impact factor: 6.998

6.  Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily.

Authors:  G Steele-Perkins; W Fang; X H Yang; M Van Gele; T Carling; J Gu; I M Buyse; J A Fletcher; J Liu; R Bronson; R B Chadwick; A de la Chapelle; X Zhang; F Speleman; S Huang
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

7.  Molecular biology of esophageal cancer.

Authors:  R Metzger; P M Schneider; U Warnecke-Eberz; J Brabender; A H Hölscher
Journal:  Onkologie       Date:  2004-04

Review 8.  Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review.

Authors:  R Montesano; M Hollstein; P Hainaut
Journal:  Int J Cancer       Date:  1996-06-21       Impact factor: 7.396

9.  Biallelic inactivation of the RIZ1 gene in human gastric cancer.

Authors:  Yutaka Tokumaru; Shuji Nomoto; Carmen Jerónimo; Rui Henrique; Susan Harden; Barry Trink; David Sidransky
Journal:  Oncogene       Date:  2003-10-09       Impact factor: 9.867

10.  Preferential loss of a polymorphic RIZ allele in human hepatocellular carcinoma.

Authors:  W Fang; Z Piao; I M Buyse; D Simon; J C Sheu; M Perucho; S Huang
Journal:  Br J Cancer       Date:  2001-03-23       Impact factor: 7.640

View more
  4 in total

1.  Synergism between RIZ1 gene therapy and paclitaxel in SiHa cervical cancer cells.

Authors:  H Y Cheng; T Zhang; Y Qu; W J Shi; G Lou; Y X Liu; Y Y Zhang; L Cheng
Journal:  Cancer Gene Ther       Date:  2016-10-07       Impact factor: 5.987

2.  Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas.

Authors:  Hua Gao; Fei Wang; Xiaolei Lan; Chuzhong Li; Jie Feng; Jiwei Bai; Lei Cao; Songbai Gui; Lichuan Hong; Yazhuo Zhang
Journal:  BMC Cancer       Date:  2015-04-12       Impact factor: 4.430

3.  PRDI-BF1-RIZ domain of retinoblastoma protein-interacting zinc finger gene 1 induces apoptosis and exerts anticancer activity in esophageal squamous cell carcinoma cells.

Authors:  Shang-Wen Dong; Yao-Wen Zhang; Yuan Chen; Shuo Wang; Pei Sun; Yuan-Guo Wang; Peng Zhang
Journal:  Oncol Lett       Date:  2014-11-05       Impact factor: 2.967

4.  Analysis of somatic microsatellite indels identifies driver events in human tumors.

Authors:  Yosef E Maruvka; Kent W Mouw; Rosa Karlic; Prasanna Parasuraman; Atanas Kamburov; Paz Polak; Nicholas J Haradhvala; Julian M Hess; Esther Rheinbay; Yehuda Brody; Amnon Koren; Lior Z Braunstein; Alan D'Andrea; Michael S Lawrence; Adam Bass; Andre Bernards; Franziska Michor; Gad Getz
Journal:  Nat Biotechnol       Date:  2017-09-11       Impact factor: 68.164

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.